Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Aug;26(4):510-3.
doi: 10.5021/ad.2014.26.4.510. Epub 2014 Jul 31.

Myxoid Cellular Neurothekeoma: A New Entity of S100-Negative, CD68-Positive Myxoid Neurothekeoma

Affiliations
Case Reports

Myxoid Cellular Neurothekeoma: A New Entity of S100-Negative, CD68-Positive Myxoid Neurothekeoma

Sook Jung Yun et al. Ann Dermatol. 2014 Aug.

Abstract

Neurothekeoma is a rare cutaneous neoplasm, occurring as a cutaneous papule or nodule on the face, shoulders, and upper extremities. Neurothekeoma has been subclassified as either the myxoid, cellular, or mixed type, depending on the amount of myxoid matrix and on immunohistochemical analysis. We observed a clinical case with conflicting histopathological and immunohistochemical findings. In this case, microscopic examination showed the typical presentation of myxoid neurothekeoma; however, immunohistochemical staining was negative for S100 protein and positive for CD68, which is the characteristic pattern of cellular neurothekeoma. We report a very rare form of myxoid cellular neurothekeoma of the face in a young woman.

Keywords: CD68; Neurothekeoma; S100 protein.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) A solitary erythematous, 0.7-×0.6-cm, telangiectatic nodule on the left eyebrow. (B) The nodule has a smooth and shiny surface with some telangiectasia.
Fig. 2
Fig. 2
Histopathological findings. (A) The tumor is in the dermis and lobulated, not encapsulated (H&E, ×20). (B~D) The tumor cells were composed of stellate and spindle-shaped cells within an abundant myxoid stroma (H&E; B: ×100, C: ×200, D: ×400).
Fig. 3
Fig. 3
Immunohistochemical findings. (A) The amount of myxoid stroma was >50% (alcian blue, ×40). (B, C) The tumor cells were positive for CD68 and vimentin (B: CD68, ×100; C: vimentin, ×100). The tumor cells were negative for S100 protein (D, ×100), CD57 (E, ×100), and glial fibrillary acidic protein (F, ×100).

References

    1. Papadopoulos EJ, Cohen PR, Hebert AA. Neurothekeoma: report of a case in an infant and review of the literature. J Am Acad Dermatol. 2004;50:129–134. - PubMed
    1. Fetsch JF, Laskin WB, Hallman JR, Lupton GP, Miettinen M. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information. Am J Surg Pathol. 2007;31:1103–1114. - PubMed
    1. Yang YW, Shih IH, Huang YH, Kuo TT, Hong HS. Mixed-type neurothekeoma presenting with an unusual clinical appearance of multiple satellite lesions on the back. Dermatol Surg. 2005;31:720–722. - PubMed
    1. Oh SH, Lee HJ, Chang SE, Lee MW, Choi JH, Moon KC, et al. A case of cellular neurothekeoma. Korean J Dermatol. 2006;44:1126–1129.
    1. Ryu DJ, Kim HJ, Jung JY, Kwon YS, Lee JH. A case of myxoid neurothekeoma on the hand. Korean J Dermatol. 2009;47:982–985.

Publication types

LinkOut - more resources